The lawyers involved in the first West Coast trial against the maker of Vioxx are butting heads over whether jurors should decide one or more of the cases at the same time.
More than 1,800 lawsuits have been filed in California against Merck & Co. Inc. alleging that executives promoted the prescription pain reliever even though they knew it might cause patients to die or suffer from heart attacks.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
